Friday, December 23, 2005


Hepatitis C Therapy - Hepatitis B and C - Awaiting New Developments


Hepatitis B and C - Awaiting New Developments
Schering-Plough said it will conduct a large clinical trial comparing its hepatitis C therapy PEG-Intron against Pegasys. Schering-Plough said the trial ...

Hepatitis C Management -- Clinical management algorithm
The future of hepatitis C therapy is likely to involve combinations of these new small-molecule drugs and PEG-IFN-based treatment. ...

Controversies in Hepatitis C Therapy
Collection of presentations for clinicians on public health considerations related to diagnosis and treatment of this disease. [Requires free registration.]

Hepatitis C
Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP; German Acute Hepatitis C Therapy Group. ...

XTLbio gets FDA fast track designation for hepatitis C therapy
XTLbio gets FDA fast track designation for hepatitis C therapy · Pipeline Insight: Hepatitis C. Rehovot, Israel, 18 July 2005 - XTL Biopharmaceuticals Ltd ...